Sanofi v. Watson Labs. Inc.

This document cites

• Federal Cases - Sanofi v. Glenmark Pharm. Inc.
• Federal Cases - Dsu Medical Corp. v. Jms Co., Ltd.
• Federal Cases - Metro-Goldwyn-Mayer Studios Inc. v. Grokster, Ltd.
• Federal Cases - Astrazeneca Lp v. Apotex Inc.
• Federal Cases - Senju Pharm. Co. v. Lupin Ltd.



See all quotations

• Federal Cases - Allergan, Inc. v. Sandoz Inc., Appeal No. 2011-1619
• Federal Cases - Regents of the Univ. of Minn. v. AGA Med. Corp.
• Federal Cases - Eli Lilly & Co. v. Teva Parenteral Medicines, Inc.
• Federal Cases - Cumberland Pharm. Inc. v. Mylan Institutional LLC
• Federal Cases - Shire Dev., LLC v. Watson Pharm., Inc.
• Federal Cases - Water Technologies Corp. v. Calco, Ltd.
• Federal Cases - Pharmastem Therapeutics, Inc. v. Viacell, Inc.
• Federal Cases - Vita-Mix Corp. v. Basic Holding, Inc.
• Federal Cases - Acco Brands, Inc. v. Aba Locks Mfrs. Co., Ltd.
• Federal Cases - Ricoh Co., Ltd. v. Quanta Computer Inc.
• Federal Cases - Manville Sales Corp. v. Paramount Systems, Inc.
• Federal Cases - Global-Tech Appliances, Inc. v. SEB S.A.
• Federal Cases - Commil USA, LLC v. Cisco Sys., Inc.
• US - Reference Stubs - Jurisdiction of the United States Court of Appeals for the Federal Circuit
• US - Reference Stubs - Infringement of patent
• US - Reference Stubs - Conditions for patentability; non-obvious subject matter
• US - Reference Stubs - New drugs
• US - Reference Stubs - Claim for Relief Arising under 35 U.S.C. Section 271(e)(2) or 42 U.S.C. Section 262